Laddar...
Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma
INTRODUCTION: Platinum-based chemotherapy is the cornerstone of treatment for patients with LUSC, but cisplatin resistance greatly restricts its clinical application. Therefore, it is particularly important to screen the predominant LUSC population using biomarkers. METHODS: Data for 15 LUSC cell li...
Sparad:
| I publikationen: | Pharmgenomics Pers Med |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7755377/ https://ncbi.nlm.nih.gov/pubmed/33376383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S264545 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|